No Data
No Data
No Data
No Data
No Data
Express News | Titan Pharmaceuticals Files FormRW Co Decided Not To Pursue The Offering Due To Market Conditions And No Longer Wishes To Conduct A Public Offering Of Securities At This Time, No Securities Covered By The Registration Statement Have Been Issued Or Sold
BenzingaApr 26 09:43 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMobile-health Network (NASDAQ:MNDR) shares rose 15.0% to $31.35 during Friday's after-market session. The company's market cap stands at $1.0 billion. Galera Therapeutics (NASDAQ:GRTX) stock in
BenzingaApr 19 16:31 ET
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday's session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ:AGEN) declined 17% to $0.4181 on Monday.
BenzingaApr 8 13:10 ET
Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical Among Healthcare Movers
Seeking AlphaApr 8 10:00 ET
The Sire Group Ltd Says Expect To Propose To Titan Pharmaceuticals Inc A Business Combination With KE Sdn. Bhd
- SEC 13D/Amended FilingAfter giving effect to these changes in membership, as of April 2, 2024, four of the board's seven directors had been nominated by the reporting persons. The reporting persons
BenzingaApr 5 16:45 ET
Titan Pharmaceuticals Overhauls Leadership, Settles With Ex-Directors
TipRanksApr 3 17:23 ET
No Data
No Data